Recursion Pharmaceuticals, Inc. (RXRX)
NASDAQ: RXRX · Real-Time Price · USD
3.780
+0.180 (5.00%)
At close: Apr 17, 2026, 4:00 PM EDT
3.800
+0.020 (0.52%)
After-hours: Apr 17, 2026, 7:59 PM EDT
Recursion Pharmaceuticals Market Cap
Recursion Pharmaceuticals has a market cap or net worth of $2 billion as of April 17, 2026. Its market cap has decreased by -6.18% in one year.
Market Cap
2.00B
Enterprise Value
1.33B
1-Year Change
-6.18%
Ranking
Category
Stock Price
$3.78
Market Cap Chart
Since April 16, 2021, Recursion Pharmaceuticals's market cap has decreased from $5.08B to $2.00B, a decrease of -60.66%. That is a compound annual growth rate of -17.00%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 17, 2026 | 2.00B | -6.20% |
| Dec 31, 2025 | 2.13B | -20.16% |
| Dec 31, 2024 | 2.67B | 24.83% |
| Dec 29, 2023 | 2.14B | 46.15% |
| Dec 30, 2022 | 1.46B | -49.51% |
| Dec 31, 2021 | 2.89B | -42.96% |
| Apr 16, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Aurinia Pharmaceuticals | 2.13B |
| Mesoblast | 2.09B |
| Agios Pharmaceuticals | 2.06B |
| Zymeworks | 2.05B |
| Capricor Therapeutics | 2.01B |
| Sionna Therapeutics | 1.96B |
| AnaptysBio | 1.94B |
| Galapagos NV | 1.92B |